Celling Biosciences, LLC
Celling Biosciences, LLC, headquartered in the United States, is a pioneering company in the regenerative medicine industry, specialising in advanced cellular therapies. Founded in 2017, Celling has rapidly established itself as a leader in the development of innovative solutions for tissue repair and regeneration, focusing on orthopaedics and sports medicine. The company’s core offerings include cutting-edge products such as the Celling Biosciences' proprietary cellular therapies, which utilise the body’s own healing mechanisms to enhance recovery. What sets Celling apart is its commitment to scientific rigor and quality, ensuring that its therapies are both effective and safe. With a strong market position, Celling Biosciences continues to achieve significant milestones, contributing to advancements in regenerative medicine and improving patient outcomes across the globe.
DitchCarbon Score
How does Celling Biosciences, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Celling Biosciences, LLC's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Celling Biosciences, LLC's reported carbon emissions
Celling Biosciences, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Celling Biosciences may still be in the early stages of developing its climate commitments or reporting frameworks. As the company operates within the biotechnology sector, it is essential for Celling Biosciences to establish clear climate goals and emissions reduction strategies to align with industry standards and expectations. Without specific emissions data or targets, it remains unclear how the company plans to address its carbon footprint and contribute to broader climate action initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Celling Biosciences, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
